Achilles Therapeutics Statistics
Total Valuation
ACHL has a market cap or net worth of $60.83 million. The enterprise value is -$21.60 million.
| Market Cap | 60.83M |
| Enterprise Value | -21.60M |
Important Dates
The last earnings date was Wednesday, May 7, 2025, before market open.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ACHL has 41.10 million shares outstanding. The number of shares has increased by 1.45% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 41.10M |
| Shares Change (YoY) | +1.45% |
| Shares Change (QoQ) | +0.18% |
| Owned by Insiders (%) | 6.51% |
| Owned by Institutions (%) | 16.40% |
| Float | 20.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.59 |
| P/TBV Ratio | 0.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.04, with a Debt / Equity ratio of 0.04.
| Current Ratio | 6.04 |
| Quick Ratio | 5.84 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -52.12% and return on invested capital (ROIC) is -33.60%.
| Return on Equity (ROE) | -52.12% |
| Return on Assets (ROA) | -30.17% |
| Return on Invested Capital (ROIC) | -33.60% |
| Return on Capital Employed (ROCE) | -69.03% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$311,065 |
| Employee Count | 215 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ACHL has paid $485,000 in taxes.
| Income Tax | 485,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +14.73% in the last 52 weeks. The beta is 1.25, so ACHL's price volatility has been higher than the market average.
| Beta (5Y) | 1.25 |
| 52-Week Price Change | +14.73% |
| 50-Day Moving Average | 1.31 |
| 200-Day Moving Average | 1.02 |
| Relative Strength Index (RSI) | 75.80 |
| Average Volume (20 Days) | 1,642,078 |
Short Selling Information
| Short Interest | 797,854 |
| Short Previous Month | 57,830 |
| Short % of Shares Out | 1.90% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.23 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -71.93M |
| Pretax Income | -64.01M |
| Net Income | -66.88M |
| EBITDA | -67.23M |
| EBIT | -71.93M |
| Earnings Per Share (EPS) | -$1.66 |
Balance Sheet
The company has $86.05 million in cash and $3.62 million in debt, giving a net cash position of $82.43 million or $2.01 per share.
| Cash & Cash Equivalents | 86.05M |
| Total Debt | 3.62M |
| Net Cash | 82.43M |
| Net Cash Per Share | $2.01 |
| Equity (Book Value) | 103.14M |
| Book Value Per Share | 2.51 |
| Working Capital | 93.16M |
Cash Flow
In the last 12 months, operating cash flow was -$63.26 million and capital expenditures -$805,000, giving a free cash flow of -$64.07 million.
| Operating Cash Flow | -63.26M |
| Capital Expenditures | -805,000 |
| Free Cash Flow | -64.07M |
| FCF Per Share | -$1.56 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ACHL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.45% |
| Shareholder Yield | n/a |
| Earnings Yield | -109.94% |
| FCF Yield | -105.32% |
Analyst Forecast
The average price target for ACHL is $4.00, which is 170.27% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.00 |
| Price Target Difference | 170.27% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -4.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |